Plasmodium falciparum has developed resistance to artemisinin in many countries in Southeast Asia.
1,2 Artemisinin combination therapy is the first-line treatment for malaria in the majority of countries in which the disease is endemic, and its efficacy is particularly important in Africa, where malaria is the most widespread.
3 We report here an artemisinin-resistant strain of
P. falciparum that was contracted in Africa.